Paper Details
- Home
- Paper Details
Topical treatment of actinic keratosis with 3.0% diclofenac in 2.5% hyaluronan gel: review of the literature about the cumulative evidence of its efficacy and safety.
Author: CozzaniEmanuele, JavorSanja, ParodiAurora
Original Abstract of the Article :
BACKGROUND: Topical 3% diclofenac in 2.5% hyaluronic acid (HA) gel is a nonsteroidal anti-inflammatory drug approved for the treatment of actinic keratosis (AK). It has been shown to be a safe and effective for treatment of AK on both skin and mucosal lip. EVIDENCE ACQUISITION: A PubMed search was ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/26512929
データ提供:米国国立医学図書館(NLM)
Treating Actinic Keratosis: A Look at Topical Diclofenac
The field of dermatology is always seeking new and effective treatments for skin conditions. This study investigates the effectiveness and safety of topical 3% diclofenac in 2.5% hyaluronic acid (HA) gel for the treatment of actinic keratosis (AK). The authors conducted a comprehensive review of the literature, analyzing data from various clinical trials. Their findings highlight the potential of this topical treatment for managing AK, while emphasizing the importance of ongoing photoprotection to minimize recurrence.
Topical Diclofenac: A Promising Treatment for Actinic Keratosis
The research demonstrates the efficacy and safety of topical 3% diclofenac in 2.5% HA gel for treating AK. This treatment has shown significant reductions in lesions when applied for extended periods, offering a valuable option for patients seeking relief from this common skin condition.
Preventing Recurrence: The Importance of Sun Protection
While topical diclofenac can effectively treat AK, the study underscores the importance of photoprotection to prevent its recurrence. Just as a desert traveler needs to protect themselves from the harsh sun, patients with AK must continue to prioritize sun protection after treatment to minimize the risk of future lesions. This proactive approach can help individuals maintain their skin health and avoid the discomfort and potential complications associated with AK.
Dr.Camel's Conclusion
Actinic keratosis, like a prickly cactus, can be a persistent and troublesome skin condition. This research provides valuable insight into the effectiveness of topical diclofenac as a treatment option for AK. It also reminds us of the importance of protecting ourselves from the sun's rays, like a desert traveler seeking shade in the scorching heat. By understanding the importance of both treatment and prevention, we can navigate the complexities of skin health and find a path towards clear and healthy skin.
Date :
- Date Completed 2017-04-17
- Date Revised 2017-04-17
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.